<ul><li>PopVax, an Indian biotech company, has secured $1.15 million in funding from the Bill and Melinda Gates Foundation.</li><li>The funding will support PopVax's research in developing lipid-polymer delivery formulations for thermostable mRNA vaccines.</li><li>This project aims to create stable vaccine formulations that can be stored at normal refrigerator temperatures, enabling rapid distribution in developing countries.</li><li>PopVax, founded in 2021, employs 70 people and is focused on developing novel mRNA vaccines and therapeutics.</li></ul>

PopVax Raises $1.15 Mn in Funding from Bill and Melinda Gates Foundation

Discover more